Karl-Dimiter Bissig

Overview:

Our group is interested in diseases of the liver, ranging from viral hepatitis to metabolic liver disorders and liver cancer. The lab specializes in human liver chimeric mice and created the first xenograft model for metabolic liver disease as well as a novel patient derived cancer model. We use these next generation humanized mouse models to develop new therapeutic approaches, such as metabolic pathway reprogramming - a CRISPR based gene therapy approach.

Positions:

Chen Family Associate Professor of Pediatrics

Pediatrics, Medical Genetics
School of Medicine

Associate Professor in Pediatrics

Pediatrics, Medical Genetics
School of Medicine

Associate Professor of Biomedical Engineering

Biomedical Engineering
Pratt School of Engineering

Associate Professor in Pharmacology and Cancer Biology

Pharmacology & Cancer Biology
School of Medicine

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Affiliate of the Duke Regeneration Center

Regeneration Next Initiative
School of Medicine

Education:

MD./PhD. 2000

Universitat Bern (Switzerland)

Residency, Internal Medicine

Inselspital (Switzerland)

Postdoctoral Fellow

Salk Institute for Biological Studies

Grants:

Physiological Dissection of the Mevalonate Pathway

Administered By
Pediatrics, Medical Genetics
Awarded By
Baylor College of Medicine
Role
Principal Investigator
Start Date
End Date

Therapeutic pathway reprogramming for metabolic liver disease

Administered By
Pediatrics, Medical Genetics
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date

Therapeutic pathway reprogramming for metabolic liver disease

Administered By
Pediatrics, Medical Genetics
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date

Therapeutic potential of CRISPR/Cas9 genome engineering in humanized mouse

Administered By
Pediatrics, Medical Genetics
Awarded By
National Institutes of Health
Role
Principal Investigator
Start Date
End Date

Physiological Dissection of the Mevalonate Pathway

Administered By
Pediatrics, Medical Genetics
Awarded By
Baylor College of Medicine
Role
Principal Investigator
Start Date
End Date

Research Areas:

Muser Mentor